135321-83-4

Basic information

• Product Name: N-[4-(N-t-butyloxycarbonyl-aminomethyl)benzoyl]-β-alanine benzyl ester
• Synonyms: N-[4-(N-t-butyloxycarbonyl-aminomethyl)benzoyl]-β-alanine benzyl ester
• CAS NO: 135321-83-4
• Molecular Weight: 412.486
• Mol File: 135321-83-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-[4-(N-t-butyloxycarbonyl-aminomethyl)benzoyl]-β-alanine benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-[4-(N-t-butyloxycarbonyl-aminomethyl)benzoyl]-β-alanine benzyl ester(135321-83-4)
• EPA Substance Registry System: N-[4-(N-t-butyloxycarbonyl-aminomethyl)benzoyl]-β-alanine benzyl ester(135321-83-4)

Safety Data

• Hazardous Substances Data: 135321-83-4(Hazardous Substances Data)

Upstream product

• 33233-67-9 4-(tert-Butoxycarbonylaminomethyl)benzoic acid 
• 14529-00-1 benzyl 3-aminopropionate 

Downstream Products

• 566180-31-2 Boc-Phe-oxymethoxycarbonyl-4-(aminomethyl)benzoyl-β-Ala-Asp(OBzl)-OTce 
• 566180-41-4 Boc-(4-aminomethylbenzoyl)-β-Ala-Asp(OBzl)-Phe-OBzl 
• 566180-32-3 Boc-Phe-oxymethoxycarbonyl-4-(aminomethyl)benzoyl-β-Ala-Asp(OBzl)-OH 
• 566180-34-5 ((9S,12S)-9-Benzyl-4,8,11,14,18-pentaoxo-5,7-dioxa-3,10,13,17-tetraaza-bicyclo[17.2.2]tricosa-1⁽²²⁾,19⁽²³⁾,20-trien-12-yl)-acetic acid benzyl ester 
• 566180-42-5 Boc-(4-aminomethylbenzoyl)-β-Ala-Asp-Phe-OH 
• 566180-38-9 Boc-Phe-oxymethoxycarbonyl-4-(aminomethyl)benzoyl-β-Ala-OBzl 
• 566180-28-7 4-(N-Boc-aminomethyl)benzoyl-β-Ala-Asp(OBzl)-OTce 
• 566180-39-0 Boc-Phe-oxymethoxycarbonyl-4-(aminomethyl)benzoyl-β-Ala-OH 
• 566180-36-7 N-[4-[[[(chloromethoxy)carbonyl]amino]methyl]benzoyl]-β-alanine benzyl ester 
• 566180-27-6 N-[4-(N-t-butyloxycarbonyl-aminomethyl)benzoyl]-β-alanine 
• 566180-35-6 N-[4-(aminomethyl)benzoyl]-β-alanine benzyl ester 

Relevant articles and documents

Synthesis and comparison of physicochemical, transport, and antithrombic properties of a cyclic prodrug and the parent RGD peptidomimetic

Cyclic prodrug 1 was derived from RGD peptidomimetic 2 by linking the amino and carboxylic acid groups via an (acyloxy)alkoxy linker. The formation of a cyclic prodrug can transiently alter the physicochemical properties of the RGD peptidomimetic. Cyclic